NASDAQ: OMDAOmada Health Inc Stock
$20.50+0.84 (+4.27%)
Updated Sep 14, 2026
OMDA Price
$20.50
Fair Value Price
N/A
Market Cap
$1.25B
52 Week Low
$10.28
52 Week High
$26.92
P/E
85.42x
P/B
4.97x
P/S
4.23x
PEG
2.77x
Dividend Yield
N/A
Revenue
$309.76M
Earnings
$4.31M
Gross Margin
68.2%
Operating Margin
1.52%
Profit Margin
1.4%
Debt to Equity
0.3
Operating Cash Flow
$24M
Beta
1.15
Next Earnings
Nov 5, 2026
Ex-Dividend
N/A
Next Dividend
N/A
OMDA Overview
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine OMDA's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +17.17% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
OMDA
Ranked#10 of 40
Ranked#10 of 40
Be the first to know about important OMDA news, forecast changes, insider trades & much more!
OMDA News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OMDA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OMDA ($20.50) is trading above its intrinsic value of $3.39, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OMDA is poor value based on its earnings relative to its share price (85.42x), compared to the US market average (43.6x)
P/E vs Market Valuation
OMDA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more OMDA due diligence checks available for Premium users.
Valuation
OMDA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
85.42x
Industry
9.64x
Market
43.6x
OMDA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
OMDA is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
OMDA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.97x
Industry
3.83x
OMDA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
OMDA price to earnings growth (PEG)
For valuing profitable companies with growth potential
OMDA is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
OMDA's financial health
Profit margin
Revenue
$87.8M
Net Income
$5.3M
Profit Margin
6%
OMDA's Earnings (EBIT) of $4.70M... subscribe to Premium to read more.
Interest Coverage Financials
OMDA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$328.2M
Liabilities
$75.5M
Debt to equity
0.3
OMDA's short-term assets ($294.91M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OMDA's short-term assets ($294.91M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OMDA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$4.0M
Investing
-$1.7M
Financing
$7.6M
OMDA's operating cash flow ($23.69M)... subscribe to Premium to read more.
Debt Coverage Financials
OMDA vs Health Information Service Stocks
Omada Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.